ArticleJAMA2018
Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas.
Article in JAMA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Pharmacy-level barriers to opioid overdose prevention: availability and accessibility of naloxone and buprenorphine-naloxone in high-risk Texas counties.Harm reduction journal · 2026Article
- Over-the-Counter Naloxone and Nonprescription Syringe Availability in Community Pharmacies.JAMA network open · 2025Article
- Price Sensitivity and Information Barriers to the Take-Up of Naloxone.American economic journal. Economic policy · 2024Article
- Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients.Journal of health economics · 2024Article
- Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial.BMJ public health · 2024Article
- Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order.The western journal of emergency medicine · 2024Article
- The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses.Drug and alcohol dependence reports · 2023Article
- Description and Evaluation of a Pilot Advanced Pharmacy Practice Experience in Addiction Medicine.American journal of pharmaceutical education · 2023Article
- Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.Drug and alcohol dependence reports · 2022Article
- If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.BMC public health · 2022Article
- Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial.Drug and alcohol dependence · 2022Article
- Pharmacy on-site overdose protocols and prevention of overdose.Substance abuse · 2022Article
- Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process.The International journal on drug policy · 2021Article
- Naloxone availability in independent community pharmacies in Georgia, 2019.Substance abuse treatment, prevention, and policy · 2021Article
- Considering the Potential Benefits of Over-the-Counter Naloxone.Integrated pharmacy research & practice · 2021Review
- The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.Drug and alcohol dependence · 2020Article
- Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default.The Hastings Center report · 2020Article
- Opioid-Related Education Provided by Continuing Education Divisions at US Pharmacy Schools.American journal of pharmaceutical education · 2020Article
- Legal requirements and recommendations to prescribe naloxone.Drug and alcohol dependence · 2020Article
- The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.The Milbank quarterly · 2020Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.